Martin J Hug
Overview
Explore the profile of Martin J Hug including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruthans J, Duftschmid G, Hammar T, Kardas P, Bertalan L, Hug M, et al.
IEEE J Biomed Health Inform
. 2025 Mar;
PP.
PMID: 40036418
While Electronic Prescription Systems (EPS) adoption varies across EU Member States, there's a lack of comprehensive comparative analysis. Existing studies focus on single EPSs, employ diverse methodologies, and lack up-to-date...
2.
Kuchlin S, Ihorst G, Heinrich S, Farassat N, Marquez Neila P, Hug M, et al.
Ophthalmology
. 2025 Jan;
PMID: 39827907
Purpose: To identify baseline clinical predictors of visual outcomes 6 months after acute optic neuritis using data from our completed clinical neuroprotection trial: Treatment of Optic Neuritis with Erythropoietin (TONE)....
3.
Alatibi K, Sumser K, Christopoulou M, Hug M, Tucci S
Biochim Biophys Acta Mol Cell Biol Lipids
. 2024 Nov;
1870(2):159582.
PMID: 39581258
No abstract available.
4.
Rapp J, Ness J, Liang P, Hug M, Agostini H, Schlunck G, et al.
J Vis Exp
. 2024 Jun;
(207).
PMID: 38884490
Angiogenesis plays a crucial role in both physiological and pathological processes within the body including tumor growth or neovascular eye disease. A detailed understanding of the underlying molecular mechanisms and...
5.
Kuchlin S, Ihorst G, Heinrich S, Marquez Neila P, Albrecht P, Hug M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Apr;
11(3):e200223.
PMID: 38588480
Background And Objectives: Optic neuritis is the most common optic neuropathy in young adults and a frequent manifestation of multiple sclerosis. Its clinical course is pertinent to the design of...
6.
Kuchlin S, Ihorst G, Heinrich S, Marquez Neila P, Albrecht P, Hug M, et al.
JAMA Neurol
. 2024 Mar;
81(5):553-554.
PMID: 38526471
No abstract available.
7.
Rapp J, Ness J, Wolf J, Hospach A, Liang P, Hug M, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jan;
1870(3):167028.
PMID: 38244944
In angiogenesis research, scientists need to carefully select appropriate in vitro models to test their hypotheses to minimize the risk for false negative or false positive study results. In this...
8.
Southern K, Addy C, Bell S, Bevan A, Borawska U, Brown C, et al.
J Cyst Fibros
. 2023 Dec;
23(1):12-28.
PMID: 38129255
This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing...
9.
Dane A, Gebbink A, Brugma J, Degrassat-Theas A, Hug M, Houlind M, et al.
Appl Health Econ Health Policy
. 2023 Sep;
21(6):905-914.
PMID: 37751107
Background: Increasing pharmaceutical expenditure challenges the sustainability and accessibility of healthcare systems across Europe. Confidentiality restraints hinder assessment of actual prices of Orphan Medicinal Products (OMPs). Hence, we assessed the...
10.
Westermann L, Rottmann F, Hug M, Staudacher D, Wobser R, Arnold F, et al.
BMC Nephrol
. 2023 Sep;
24(1):260.
PMID: 37661268
No abstract available.